|
|
Prepublished online as a Blood First Edition Paper on May 13, 2002; DOI 10.1182/blood-2001-12-0327.
Previous Article | Table of Contents | Next Article 
Blood, 1 September 2002, Vol. 100, No. 5, pp. 1810-1816
NEOPLASIA
Spontaneous and drug-induced apoptosis is mediated by
conformational changes of Bax and Bak in B-cell chronic
lymphocytic leukemia
Beatriz Bellosillo,
Neus Villamor,
Armando López-Guillermo,
Silvia Marcé,
Francesc Bosch,
Elias Campo,
Emili Montserrat, and
Dolors Colomer
From the Departments of Hematology and Pathology,
Institute of Hematology and Oncology from Hospital Clínic,
Postgraduate School of Hematology Farreras-Valentí; Institut
d'Investigacions Biomèdiques August Pi i Sunyer; and University
of Barcelona, Spain.
The role of Bax and Bak, 2 proapoptotic proteins of the Bcl-2
family, was analyzed in primary B-cell chronic lymphocytic leukemia (CLL) cells following in vitro treatment with fludarabine,
dexamethasone, or the combination of fludarabine with cyclophosphamide
and mitoxantrone (FCM). A strong correlation was found between the
number of apoptotic cells and the percentage of cells stained with
antibodies recognizing conformational changes of Bax (n = 33;
r = 0.836; P < .001) or Bak (n = 10;
r = 0.948; P < .001). Preincubation
of CLL cells with Z-VAD.fmk
(N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethyl ketone), a
broad caspase inhibitor, abolished caspase-3 activation, exposure of
phosphatidylserine residues, and reactive oxygen species
generation; partially reversed the loss of transmembrane
mitochondrial potential ( m); but did not affect Bax or Bak
conformational changes. These results indicate that the conformational
changes of Bax and Bak occur upstream of caspase activation or are
caspase independent. Following drug-induced apoptosis, Bax
integrates into mitochondria, as demonstrated by fluorescence
microscopy and Western blot, without changes in the total amount of Bax
or Bak protein. Fludarabine and FCM induce p53 stabilization, but do
not seem to be essential in inducing Bax and Bak conformational
changes, as they are also observed in dexamethasone-treated CLL cells.
These results demonstrate that, in CLL cells, the change in the
intracellular localization of Bax from cytosol to mitochondria and the
conformational changes of Bax and Bak are among the early steps
in the induction of cell death.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Gine, M. Crespo, A. Muntanola, E. Calpe, M. J. Baptista, N. Villamor, E. Montserrat, and F. Bosch
Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment
Haematologica,
January 1, 2008;
93(1):
75 - 82.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Laane, T. Panaretakis, K. Pokrovskaja, E. Buentke, M. Corcoran, S. Soderhall, M. Heyman, J. Mazur, B. Zhivotovsky, A. Porwit, et al.
Dexamethasone-induced apoptosis in acute lymphoblastic leukemia involves differential regulation of Bcl-2 family members
Haematologica,
November 1, 2007;
92(11):
1460 - 1469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bras, V. J. Yuste, G. Roue, S. Barbier, P. Sancho, C. Virely, M. Rubio, S. Baudet, J. E. Esquerda, H. Merle-Beral, et al.
Drp1 Mediates Caspase-Independent Type III Cell Death in Normal and Leukemic Cells
Mol. Cell. Biol.,
October 15, 2007;
27(20):
7073 - 7088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Zhao, R. Lapalombella, T. Joshi, C. Cheney, A. Gowda, M. S. Hayden-Ledbetter, P. R. Baum, T. S. Lin, D. Jarjoura, A. Lehman, et al.
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical
Blood,
October 1, 2007;
110(7):
2569 - 2577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Perez-Galan, G. Roue, N. Villamor, E. Campo, and D. Colomer
The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak
Blood,
May 15, 2007;
109(10):
4441 - 4449.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kojima, M. Konopleva, I. J. Samudio, V. Ruvolo, and M. Andreeff
Mitogen-Activated Protein Kinase Kinase Inhibition Enhances Nuclear Proapoptotic Function of p53 in Acute Myelogenous Leukemia Cells
Cancer Res.,
April 1, 2007;
67(7):
3210 - 3219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kojima, M. Konopleva, T. McQueen, S. O'Brien, W. Plunkett, and M. Andreeff
Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia
Blood,
August 1, 2006;
108(3):
993 - 1000.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marce, O. Balague, L. Colomo, A. Martinez, S. Holler, N. Villamor, F. Bosch, G. Ott, A. Rosenwald, L. Leoni, et al.
Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy.
Clin. Cancer Res.,
June 15, 2006;
12(12):
3754 - 3761.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Perez-Galan, G. Roue, N. Villamor, E. Montserrat, E. Campo, and D. Colomer
The proteasome inhibitor bortezomib induces apoptosis in mantle-cell lymphoma through generation of ROS and Noxa activation independent of p53 status
Blood,
January 1, 2006;
107(1):
257 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kashkar, K. Wiegmann, B. Yazdanpanah, D. Haubert, and M. Kronke
Acid Sphingomyelinase Is Indispensable for UV Light-induced Bax Conformational Change at the Mitochondrial Membrane
J. Biol. Chem.,
May 27, 2005;
280(21):
20804 - 20813.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Ramos, C. Fernandez, D. Amran, P. Sancho, E. de Blas, and P. Aller
Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells
Blood,
May 15, 2005;
105(10):
4013 - 4020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Gillespie, X. D. Zhang, and P. Hersey
Variable expression of protein kinase C{varepsilon} in human melanoma cells regulates sensitivity to TRAIL-induced apoptosis
Mol. Cancer Ther.,
April 1, 2005;
4(4):
668 - 676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Starczynski, C. Pepper, G. Pratt, L. Hooper, A. Thomas, D. Milligan, P. Bentley, and C. Fegan
Common Polymorphism G(-248)A in the Promoter Region of the bax Gene Results in Significantly Shorter Survival in Patients With Chronic Lymphocytic Leukemia Once Treatment Is Initiated
J. Clin. Oncol.,
March 1, 2005;
23(7):
1514 - 1521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Ahmad, K. B. Iskandar, J. L. Hirpara, M.-V. Clement, and S. Pervaiz
Hydrogen Peroxide-Mediated Cytosolic Acidification Is a Signal for Mitochondrial Translocation of Bax during Drug-Induced Apoptosis of Tumor Cells
Cancer Res.,
November 1, 2004;
64(21):
7867 - 7878.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xiao, Y. Zhong, W. Greene, F. Dong, and G. Zhong
Chlamydia trachomatis Infection Inhibits Both Bax and Bak Activation Induced by Staurosporine
Infect. Immun.,
September 1, 2004;
72(9):
5470 - 5474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Yilmaz, T. Jungas, P. Verbeke, and D. M. Ojcius
Activation of the Phosphatidylinositol 3-Kinase/Akt Pathway Contributes to Survival of Primary Epithelial Cells Infected with the Periodontal Pathogen Porphyromonas gingivalis
Infect. Immun.,
July 1, 2004;
72(7):
3743 - 3751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Y. Almawi, O. K. Melemedjian, and M. M. A. Jaoude
On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis
J. Leukoc. Biol.,
July 1, 2004;
76(1):
7 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Decker, M. Oelsner, R. J. Kreitman, G. Salvatore, Q.-c. Wang, I. Pastan, C. Peschel, and T. Licht
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins
Blood,
April 1, 2004;
103(7):
2718 - 2726.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Mascarell, R. Auger, A. Alcover, D. M. Ojcius, T. Jungas, V. Cadet-Daniel, J. M. Kanellopoulos, and P. Truffa-Bachi
Characterization of a Gene Encoding Two Isoforms of a Mitochondrial Protein Up-regulated by Cyclosporin A in Activated T Cells
J. Biol. Chem.,
March 12, 2004;
279(11):
10556 - 10563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Beaupre, E. Cepero, E. A. Obeng, L. H. Boise, and M. G. Lichtenheld
R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways
Mol. Cancer Ther.,
February 1, 2004;
3(2):
179 - 186.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. D. Zhang, S. K. Gillespie, and P. Hersey
Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways
Mol. Cancer Ther.,
February 1, 2004;
3(2):
187 - 197.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-G. Hur, Y. Yun, and J. Won
Rosmarinic Acid Induces p56lck-Dependent Apoptosis in Jurkat and Peripheral T Cells via Mitochondrial Pathway Independent from Fas/Fas Ligand Interaction
J. Immunol.,
January 1, 2004;
172(1):
79 - 87.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z.-q. Yuan, R. I. Feldman, G. E. Sussman, D. Coppola, S. V. Nicosia, and J. Q. Cheng
AKT2 Inhibition of Cisplatin-induced JNK/p38 and Bax Activation by Phosphorylation of ASK1: IMPLICATION OF AKT2 IN CHEMORESISTANCE
J. Biol. Chem.,
June 20, 2003;
278(26):
23432 - 23440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Crespo, F. Bosch, N. Villamor, B. Bellosillo, D. Colomer, M. Rozman, S. Marce, A. Lopez-Guillermo, E. Campo, and E. Montserrat
ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic Leukemia
N. Engl. J. Med.,
May 1, 2003;
348(18):
1764 - 1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Del Poeta, A. Venditti, M. I. Del Principe, L. Maurillo, F. Buccisano, A. Tamburini, M. C. Cox, A. Franchi, A. Bruno, C. Mazzone, et al.
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)
Blood,
March 15, 2003;
101(6):
2125 - 2131.
[Abstract]
[Full Text]
[PDF]
|
 |
|
| |